Страна: Великобритания
Язык: английский
Источник: HMA (Heads of Medicines Agencies)
butorphanol tartrate 10 mg/ml
ALVETRA u. WERFFT AG
QN02AF01
Solution for injection
butorphanol
Cats Non Food, Dogs Non Food, Horses Food
2011-03-23
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml Alvegesic 10 mg/ml (ES, PT) Solution for injection for Horses, Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection contains: Active substance: Butorphanol tartrate 14.58 mg equivalent to 10.00 mg Butorphanol Excipients: Benzethonium chloride 0.10 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear, colourless solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horse, Dog, Cat. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES HORSE As an analgesic: For relief of moderate to severe abdominal pain (alleviates abdominal pain associated with colic of gastrointestinal origin). As a sedative: For sedation after the administration of certain alpha2-adrenoceptor agonists (detomidine, romifidine). DOG As an analgesic: For relief of moderate visceral pain. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As a pre-anaesthetic: For pre-anaesthesia as sole agent and in combination with acepromazine. As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine. CAT As an analgesic for the relief of moderate pain: For pre-operative analgesia in combination with acepromazine/ketamine or xylazine/ketamine. For post- operative analgesia after small surgical procedures. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As an anaesthetic: For anaesthesia Прочитать полный документ